Katherine E. Warren

8.4k total citations
116 papers, 3.0k citations indexed

About

Katherine E. Warren is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Katherine E. Warren has authored 116 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Genetics, 38 papers in Neurology and 34 papers in Molecular Biology. Recurrent topics in Katherine E. Warren's work include Glioma Diagnosis and Treatment (74 papers), Neuroblastoma Research and Treatments (32 papers) and Cancer therapeutics and mechanisms (10 papers). Katherine E. Warren is often cited by papers focused on Glioma Diagnosis and Treatment (74 papers), Neuroblastoma Research and Treatments (32 papers) and Cancer therapeutics and mechanisms (10 papers). Katherine E. Warren collaborates with scholars based in United States, United Kingdom and Italy. Katherine E. Warren's co-authors include Roger J. Packer, Frank M. Balis, Brigitte C. Widemann, Russell R. Lonser, Stewart Goldman, Ian F. Pollack, Alberta Aikin, Gilbert Vézina, Joanna H. Shih and Tina Young Poussaint and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Katherine E. Warren

114 papers receiving 2.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine E. Warren United States 33 1.7k 892 856 513 489 116 3.0k
Andrew D. Norden United States 39 2.2k 1.3× 1.1k 1.3× 1.1k 1.2× 604 1.2× 724 1.5× 122 4.9k
Jennifer Marcello United States 21 2.0k 1.2× 888 1.0× 379 0.4× 658 1.3× 330 0.7× 34 3.1k
Helen Wheeler Australia 27 1.4k 0.8× 849 1.0× 267 0.3× 671 1.3× 331 0.7× 110 2.6k
Katherine B. Peters United States 35 2.3k 1.4× 1.3k 1.5× 627 0.7× 1.1k 2.2× 510 1.0× 230 4.6k
Sara Erridge United Kingdom 24 1.7k 1.0× 674 0.8× 291 0.3× 515 1.0× 652 1.3× 67 3.0k
John L. Villano United States 34 2.6k 1.6× 1.1k 1.3× 1.1k 1.2× 819 1.6× 504 1.0× 141 5.0k
Steve Braunstein United States 34 891 0.5× 1.2k 1.4× 496 0.6× 1.0k 2.0× 779 1.6× 205 4.2k
M. Bamberg Germany 34 1.1k 0.7× 845 0.9× 538 0.6× 746 1.5× 544 1.1× 223 3.9k
Frank S. Lieberman United States 38 2.5k 1.5× 1.5k 1.7× 709 0.8× 1.6k 3.0× 689 1.4× 139 5.0k
Mark G. Malkin United States 29 1.8k 1.1× 414 0.5× 386 0.5× 627 1.2× 828 1.7× 71 3.2k

Countries citing papers authored by Katherine E. Warren

Since Specialization
Citations

This map shows the geographic impact of Katherine E. Warren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E. Warren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E. Warren more than expected).

Fields of papers citing papers by Katherine E. Warren

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E. Warren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E. Warren. The network helps show where Katherine E. Warren may publish in the future.

Co-authorship network of co-authors of Katherine E. Warren

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine E. Warren. A scholar is included among the top collaborators of Katherine E. Warren based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine E. Warren. Katherine E. Warren is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cannaby, Ann‐Marie, et al.. (2022). Evaluation of the effect of a Nursing System Framework on Nurse Sensitive Indicators, mortality and readmission in an NHS Trust. Nursing Open. 10(2). 953–966. 2 indexed citations
2.
Soffietti, Riccardo, Chetan Bettegowda, Ingo K. Mellinghoff, et al.. (2022). Liquid biopsy in gliomas: A RANO review and proposals for clinical applications. Neuro-Oncology. 24(6). 855–871. 63 indexed citations
3.
Vogelzang, Jayne, et al.. (2022). Clinical Trial Enrollment Among Adolescent and Young Adults with Primary Central Nervous System Tumors Treated at the Dana-Farber Cancer Institute. Journal of Adolescent and Young Adult Oncology. 11(6). 543–549. 2 indexed citations
4.
Fangusaro, Jason, Maria Giuseppina Cefalo, Maria Luisa Garrè, et al.. (2021). Phase 2 Study of Pomalidomide (CC-4047) Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Tumors. Frontiers in Oncology. 11. 660892–660892. 6 indexed citations
5.
McCully, Cynthia, et al.. (2020). Characterizing the pharmacokinetics of panobinostat in a non-human primate model for the treatment of diffuse intrinsic pontine glioma. Cancer Chemotherapy and Pharmacology. 85(4). 827–830. 10 indexed citations
6.
Panditharatna, Eshini, Lindsay Kilburn, Mariam Aboian, et al.. (2018). Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy. Clinical Cancer Research. 24(23). 5850–5859. 123 indexed citations
7.
Yuan, Ying, Ruitao Lin, Daniel Li, Lei Nie, & Katherine E. Warren. (2018). Time-to-Event Bayesian Optimal Interval Design to Accelerate Phase I Trials. Clinical Cancer Research. 24(20). 4921–4930. 84 indexed citations
8.
Arvold, Nils D., Terri S. Armstrong, Katherine E. Warren, et al.. (2018). Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working Group. Neuro-Oncology. 20(7). 897–906. 37 indexed citations
9.
Withrow, Diana R., Amy Berrington de González, Clara Lam, Katherine E. Warren, & Meredith S. Shiels. (2018). Trends in Pediatric Central Nervous System Tumor Incidence in the United States, 1998–2013. Cancer Epidemiology Biomarkers & Prevention. 28(3). 522–530. 29 indexed citations
10.
Warren, Katherine E., et al.. (2017). The Role of Public Health in Combatting Synthetic Cannabinoid Use in Adolescents. Journal of Adolescent Health. 60(5). 483–486. 3 indexed citations
11.
Warren, Katherine E. & Leana S. Wen. (2016). Measles, social media and surveillance in Baltimore City. Journal of Public Health. 39(3). e73–e78. 15 indexed citations
12.
Ahsan, Sama, Eric H. Raabe, Michael C. Haffner, et al.. (2014). Increased 5-hydroxymethylcytosine and decreased 5-methylcytosine are indicators of global epigenetic dysregulation in diffuse intrinsic pontine glioma. Acta Neuropathologica Communications. 2(1). 59–59. 33 indexed citations
13.
Sarlls, Joelle E., et al.. (2014). Diffusion Tensor Histogram Analysis of Pediatric Diffuse Intrinsic Pontine Glioma. BioMed Research International. 2014. 1–9. 11 indexed citations
14.
Venzon, David, et al.. (2012). Single- and Multivoxel Proton Spectroscopy in Pediatric Patients With Diffuse Intrinsic Pontine Glioma. International Journal of Radiation Oncology*Biology*Physics. 84(3). 774–779. 24 indexed citations
15.
Hammoud, Dima A., et al.. (2011). Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging. Neuro-Oncology. 13(8). 904–909. 62 indexed citations
16.
Warren, Katherine E.. (2009). Noninvasive assessment of pediatric brain tumors. Cancer Biology & Therapy. 8(20). 1881–1888. 3 indexed citations
17.
Fitzhugh, Courtney D., Barbara Wise, Kristin Baird, et al.. (2009). Secondary supratentorial primitive neuroectodermal tumor following treatment of childhood osteosarcoma. Pediatric Blood & Cancer. 53(3). 496–498. 2 indexed citations
18.
Warren, Katherine E., et al.. (2007). Plasma and cerebrospinal fluid pharmacokinetics of the histone deacetylase inhibitor, belinostat (PXD101), in non-human primates. Cancer Chemotherapy and Pharmacology. 62(3). 433–437. 23 indexed citations
19.
Packer, Roger J., Mark Krailo, Minesh P. Mehta, et al.. (2005). A Phase I study of concurrent RMP‐7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas. Cancer. 104(9). 1968–1974. 33 indexed citations
20.
Warren, Katherine E., Mahendra Patel, Alberta Aikin, et al.. (2001). Phase I trial of lobradimil (RMP-7) and carboplatin in children with brain tumors. Cancer Chemotherapy and Pharmacology. 48(4). 275–282. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrew D. Norden Breakdown of academic impact, for papers by Jennifer Marcello Breakdown of academic impact, for papers by Helen Wheeler Breakdown of academic impact, for papers by Katherine B. Peters Breakdown of academic impact, for papers by Sara Erridge Breakdown of academic impact, for papers by John L. Villano Breakdown of academic impact, for papers by Steve Braunstein Breakdown of academic impact, for papers by M. Bamberg Breakdown of academic impact, for papers by Frank S. Lieberman Breakdown of academic impact, for papers by Mark G. Malkin
Rankless by CCL
2026